Title
Hybrid System Modeling: Using the Parallel DEVS Formalism and the Modelica Language,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
The objective of the presented work is to facilitate the description of discreteevent models and the discreteevent part of hybridDAE models. It is achieved by combining the Parallel DEVS formalism, the processoriented modeling approach and the Modelica language. This objective not only includes the description of PDEVS and processoriented models in Modelica, but also developing interface models which will facilitate the combination of these models with other continuoustime or discreteevent Modelica models. The development of this work includes the identification and analysis of the requirements needed to describe PDEVS and processoriented models in Modelica, the description and implementation of a message passing mechanism in Modelica, the implementation of the requirements analyzed into new Modelica libraries that facilitate the description of models using current Modelica functionalities, the combination of these new libraries with other Modelica libraries and the validation of the developed models using case studies and benchmarking systems.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.